CytoSorbents Corporation (CTSO) - Product Pipeline Analysis, 2013 Update: New Research Report Available at Fast Market Research
CytoSorbents Corporation (CytoSorbents) is a therapeutic device company. The company designs and develops blood purification technology to treat life-threatening illnesses. It also conducts clinical trials and develops adsorbent polymer technology to provide blood purification for acute and chronic health complications associated with blood toxicity. CytoSorbents' flagship technologies include BetaSorb, HemoDefend and CytoSorb. CytoSorbents' BetaSorb is used for the conduction of traditional high-flux hemodialysis treatment for the kidneys. The company's CytoSorb technology is under development stage, which is used to reduce...
View full press release